BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khorram-manesh A, Ahlman H, Nilsson O, Odén A, Jansson S. Mortality associated with pheochromocytoma in a large Swedish cohort. European Journal of Surgical Oncology (EJSO) 2004;30:556-9. [DOI: 10.1016/j.ejso.2004.03.006] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Elliott PF, Berhane T, Ragnarsson O, Falhammar H. Ectopic ACTH- and/or CRH-Producing Pheochromocytomas. J Clin Endocrinol Metab 2021;106:598-608. [PMID: 32710791 DOI: 10.1210/clinem/dgaa488] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Lee M, Langsjeon D, Devabhaktuni S, Olsovsky G. Pheochromocytoma and sinus node dysfunction. Proc (Bayl Univ Med Cent) 2019;32:119-20. [PMID: 30956604 DOI: 10.1080/08998280.2018.1533310] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Reisch N, Peczkowska M, Januszewicz A, Neumann HP. Pheochromocytoma: presentation, diagnosis and treatment. J Hypertens 2006;24:2331-9. [PMID: 17082709 DOI: 10.1097/01.hjh.0000251887.01885.54] [Cited by in Crossref: 116] [Cited by in F6Publishing: 77] [Article Influence: 8.3] [Reference Citation Analysis]
4 Ellis RJ, Patel D, Prodanov T, Sadowski S, Nilubol N, Adams K, Steinberg SM, Pacak K, Kebebew E. Response after surgical resection of metastatic pheochromocytoma and paraganglioma: can postoperative biochemical remission be predicted? J Am Coll Surg 2013;217:489-96. [PMID: 23891076 DOI: 10.1016/j.jamcollsurg.2013.04.027] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
5 Ebbehoj A, Jacobsen SF, Trolle C, Robaczyk MG, Rasmussen ÅK, Feldt-Rasmussen U, Thomsen RW, Poulsen PL, Stochholm K, Søndergaard E. Pheochromocytoma in Denmark during 1977-2016: validating diagnosis codes and creating a national cohort using patterns of health registrations. Clin Epidemiol 2018;10:683-95. [PMID: 29942158 DOI: 10.2147/CLEP.S163065] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
6 Falhammar H, Kjellman M, Calissendorff J. Initial clinical presentation and spectrum of pheochromocytoma: a study of 94 cases from a single center. Endocr Connect. 2018;7:186-192. [PMID: 29217652 DOI: 10.1530/ec-17-0321] [Cited by in Crossref: 33] [Cited by in F6Publishing: 19] [Article Influence: 8.3] [Reference Citation Analysis]
7 Denis A, Mirallie E, Dru D, Autain Renaudin K, Kraeber-bodéré F, Ansquer C. Apport de la TEP/TDM au 18 FDG dans le bilan préopératoire des phéochromocytomes. Étude rétrospective comparative par rapport à la scintigraphie à la MIBG. Médecine Nucléaire 2018;42:104-13. [DOI: 10.1016/j.mednuc.2018.01.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Pacak K, Ilias I, Adams KT, Eisenhofer G. Biochemical diagnosis, localization and management of pheochromocytoma: focus on multiple endocrine neoplasia type 2 in relation to other hereditary syndromes and sporadic forms of the tumour. J Intern Med 2005;257:60-8. [PMID: 15606377 DOI: 10.1111/j.1365-2796.2004.01425.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 41] [Article Influence: 3.8] [Reference Citation Analysis]
9 Haine SE, Miljoen HP, Blankoff I, Vrints CJ. Atrioventricular dissociation due to pheochromocytoma in a young adult. Clin Cardiol 2010;33:E65-7. [PMID: 20865751 DOI: 10.1002/clc.20645] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Uslar T, San Francisco IF, Olmos R, Macchiavelo S, Zuñiga A, Rojas P, Garrido M, Huete A, Mendez GP, Cortinez I, Zemelman JT, Cifuentes J, Castro F, Olivari D, Domínguez JM, Arteaga E, Fardella CE, Valdés G, Tagle R, Baudrand R. Clinical Presentation and Perioperative Management of Pheochromocytomas and Paragangliomas: A 4-Decade Experience. J Endocr Soc 2021;5:bvab073. [PMID: 34377881 DOI: 10.1210/jendso/bvab073] [Reference Citation Analysis]
11 Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, Naruse M, Pacak K, Young WF Jr;  Endocrine Society. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99:1915-1942. [PMID: 24893135 DOI: 10.1210/jc.2014-1498] [Cited by in Crossref: 1156] [Cited by in F6Publishing: 787] [Article Influence: 165.1] [Reference Citation Analysis]
12 Gao S, Liu L, Li Z, Pang Y, Shi J, Zhu F. Seven Novel Genes Related to Cell Proliferation and Migration of VHL-Mutated Pheochromocytoma. Front Endocrinol (Lausanne) 2021;12:598656. [PMID: 33828526 DOI: 10.3389/fendo.2021.598656] [Reference Citation Analysis]
13 Tsoli M, Daskalakis K, Kassi E, Kaltsas G, Tsolakis AV. A Critical Appraisal of Contemporary and Novel Biomarkers in Pheochromocytomas and Adrenocortical Tumors. Biology (Basel) 2021;10:580. [PMID: 34201922 DOI: 10.3390/biology10070580] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Rai HK, Reddy K. Extensive Fever of Unknown Origin (FUO) Workup to Unmask Pheochromocytoma. Cureus 2021;13:e15218. [PMID: 34178537 DOI: 10.7759/cureus.15218] [Reference Citation Analysis]
15 Rey Chaves CE, Ayala D, García G, Conde Monroy D, Sabogal Olarte JC. Retroperitoneal pheochromocytoma: Unsual presentation and atypical location. Int J Surg Case Rep 2021;85:106248. [PMID: 34352621 DOI: 10.1016/j.ijscr.2021.106248] [Reference Citation Analysis]
16 Khorram-Manesh A, Ahlman H, Nilsson O, Friberg P, Odén A, Stenström G, Hansson G, Stenquist O, Wängberg B, Tisell LE, Jansson S. Long-term outcome of a large series of patients surgically treated for pheochromocytoma. J Intern Med 2005;258:55-66. [PMID: 15953133 DOI: 10.1111/j.1365-2796.2005.01504.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 3.1] [Reference Citation Analysis]
17 Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet. 2005;366:665-675. [PMID: 16112304 DOI: 10.1016/s0140-6736(05)67139-5] [Cited by in Crossref: 1015] [Cited by in F6Publishing: 315] [Article Influence: 63.4] [Reference Citation Analysis]
18 Kim JH, Moon H, Noh J, Lee J, Kim SG. Epidemiology and Prognosis of Pheochromocytoma/Paraganglioma in Korea: A Nationwide Study Based on the National Health Insurance Service. Endocrinol Metab (Seoul) 2020;35:157-64. [PMID: 32207276 DOI: 10.3803/EnM.2020.35.1.157] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
19 Fitzgerald PA, Goldsby RE, Huberty JP, Price DC, Hawkins RA, Veatch JJ, Cruz FD, Jahan TM, Linker CA, Damon L, Matthay KK. Malignant Pheochromocytomas and Paragangliomas: A Phase II Study of Therapy with High-Dose 131I-Metaiodobenzylguanidine (131I-MIBG). Annals of the New York Academy of Sciences 2006;1073:465-90. [DOI: 10.1196/annals.1353.050] [Cited by in Crossref: 75] [Cited by in F6Publishing: 60] [Article Influence: 5.0] [Reference Citation Analysis]